DNAVision is a leading provider of applied pharmacogenetic & pharmacogenomic services.
DNAVision offers the powerful combination of different technologies in expression profiling, SNP genotyping and sequencing in a high quality environment. DNAVision is a spin-off of BioVallée, University of Brussels and Institute of Pathology and Genetics. More information on DNAVision’s service portfolio can be found on www.dnavision.be


Private Company